Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

• SHAH NP

収録刊行物

• Cancer Cell

  Cancer Cell 2 117-125, 2002

詳細情報

• CRID: 1571135650386660736
• NII論文ID: 10018174337
• データソース種別:
  • CiNii Articles